A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J. Swen, Roelof Bosch, Kathrin Blagec et al.|The Lancet|2023Cited by 508
Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trialFéline P B Kroon, M. Kloppenburg, Marion C Kortekaas et al.|The Lancet|2019Cited by 128